PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 22001376-1 2012 Biglycan (BGN) is a small proteoglycan that consists of a protein core containing leucine-rich repeat regions and two glycosaminoglycan (GAG) chains of either chondroitin sulfate (CS) or dermatan sulfate (DS) type. Dermatan Sulfate 187-203 biglycan Homo sapiens 0-8 28199387-5 2017 Using the plasmon surface resonance method, we showed that DS chains, especially those of biglycan, are good binding partners for TG2. Dermatan Sulfate 59-61 biglycan Homo sapiens 90-98 22001376-1 2012 Biglycan (BGN) is a small proteoglycan that consists of a protein core containing leucine-rich repeat regions and two glycosaminoglycan (GAG) chains of either chondroitin sulfate (CS) or dermatan sulfate (DS) type. Dermatan Sulfate 187-203 biglycan Homo sapiens 10-13 22001376-1 2012 Biglycan (BGN) is a small proteoglycan that consists of a protein core containing leucine-rich repeat regions and two glycosaminoglycan (GAG) chains of either chondroitin sulfate (CS) or dermatan sulfate (DS) type. Dermatan Sulfate 205-207 biglycan Homo sapiens 0-8 22001376-1 2012 Biglycan (BGN) is a small proteoglycan that consists of a protein core containing leucine-rich repeat regions and two glycosaminoglycan (GAG) chains of either chondroitin sulfate (CS) or dermatan sulfate (DS) type. Dermatan Sulfate 205-207 biglycan Homo sapiens 10-13 22001376-2 2012 The development of novel, highly efficient analytical methods for structural identification of BGN-derived CS/DS motifs, possibly implicated in biological events, is currently the focus of research. Dermatan Sulfate 110-112 biglycan Homo sapiens 95-98 22001376-4 2012 The CS/DS chains were released from transfected 293 BGN by beta-elimination. Dermatan Sulfate 7-9 biglycan Homo sapiens 52-55 14704908-6 2004 RESULTS: Degradation of the samples with chondroitinases ABC, AC and B revealed that, in the aqueous humour from PEX eyes, collagen type IX and biglycan had a more dermatan sulphate than did normal eyes. Dermatan Sulfate 164-181 biglycan Homo sapiens 144-152 9727420-7 1998 The increases were associated with highly charged molecular forms of decorin and biglycan, indicating modification of the proteins with dermatan sulfate chains of increased sulfation. Dermatan Sulfate 136-152 biglycan Homo sapiens 81-89 11853965-8 2002 Dermatan sulfate (DS) was the predominant glycosaminoglycan (GAG) present on biglycan and decorin in both tissues. Dermatan Sulfate 0-16 biglycan Homo sapiens 77-85 11853965-8 2002 Dermatan sulfate (DS) was the predominant glycosaminoglycan (GAG) present on biglycan and decorin in both tissues. Dermatan Sulfate 18-20 biglycan Homo sapiens 77-85 9727420-9 1998 CONCLUSIONS: The increased dermatan sulfate associated with chronic corneal pathologic conditions results from stromal accumulation of decorin and particularly of biglycan in the affected corneas. Dermatan Sulfate 27-43 biglycan Homo sapiens 163-171 10749870-0 2000 Altered dermatan sulfate structure and reduced heparin cofactor II-stimulating activity of biglycan and decorin from human atherosclerotic plaque. Dermatan Sulfate 8-24 biglycan Homo sapiens 91-99 10749870-1 2000 Biglycan and decorin are small dermatan sulfate-containing proteoglycans in the extracellular matrix of the artery wall. Dermatan Sulfate 31-47 biglycan Homo sapiens 0-8 8440685-1 1993 Two small interstitial dermatan sulfate-containing proteoglycans, biglycan and decorin, are present in extracellular matrices of skin, tendon, ligament, and cartilage. Dermatan Sulfate 23-39 biglycan Homo sapiens 66-74 7919526-9 1994 Decorin and biglycan possess one and two dermatan sulfate chains, respectively, whereas fibromodulin bears several keratan sulfate chains. Dermatan Sulfate 41-57 biglycan Homo sapiens 12-20 8317997-5 1993 Dermatan sulphate was the predominant glycosaminoglycan present on biglycan and decorin in annulus fibrosus extracts, whereas chondroitin 4-sulphate was present in both small proteoglycans isolated from cartilage end-plate. Dermatan Sulfate 0-17 biglycan Homo sapiens 67-75 1555588-10 1992 However, the dermatan sulphate chains on biglycan and decorin from TGF-beta treated cultures contained a larger proportion of D-glucuronosyl residues than those derived from untreated cultures. Dermatan Sulfate 13-30 biglycan Homo sapiens 41-49 2287949-3 1990 Carbohydrate substituants (one or two chondroitin sulfate/dermatan sulfate chains for decorin and biglycan respectively, chains of keratan sulfate for fibromodulin and oligosaccharides) present variations from tissue to tissue and with age and other factors. Dermatan Sulfate 58-74 biglycan Homo sapiens 98-106 1576824-3 1992 The dermatan sulfate proteoglycans (DS-PGI and DS-PGII) were detected in normal and osteoarthritic cartilage. Dermatan Sulfate 4-20 biglycan Homo sapiens 39-42 2590169-4 1989 Both dermatan sulphate proteoglycan I (DS-PGI) and dermatan sulphate proteoglycan II (DS-PGII) were identified and the former was present in greater abundance. Dermatan Sulfate 5-22 biglycan Homo sapiens 42-45 2407884-3 1990 In control experiments we found that mesangial cells produced two distinct proteoglycans identified as the small chondroitin/dermatan sulfate proteoglycans biglycan (PG I) and decorin (PG II) by showing that their mobility on SDS-PAGE changed upon digestion by chondroitinase ABC, and that they reacted with antibodies raised against synthetic peptides from the core protein sequence of human biglycan and decorin. Dermatan Sulfate 125-141 biglycan Homo sapiens 156-164 2407884-3 1990 In control experiments we found that mesangial cells produced two distinct proteoglycans identified as the small chondroitin/dermatan sulfate proteoglycans biglycan (PG I) and decorin (PG II) by showing that their mobility on SDS-PAGE changed upon digestion by chondroitinase ABC, and that they reacted with antibodies raised against synthetic peptides from the core protein sequence of human biglycan and decorin. Dermatan Sulfate 125-141 biglycan Homo sapiens 166-170 2590169-7 1989 Sequence analysis of the N-terminal 20 amino acid residues reveals the presence of a single site for the potential substitution of dermatan sulphate at residue 4 of DS-PGII and two such sites at residues 5 and 10 for DS-PGI. Dermatan Sulfate 131-148 biglycan Homo sapiens 165-171